Internal medicine and rheumatology specialist Siobhan Deshauer, MD, delves into a medical mystery triggered by a puffed bean ...

How do you send drugs to specific parts of the body so they do their job and avoid causing side effects elsewhere? According to researchers at Stanford University, the answer is a combination of ...

Ultrasound is a non-invasive imaging technique that uses the differential reflectance of acoustic waves at ultrasonic frequencies to detect objects and measure distances. It is commonly used for ...

The association of primary sclerosing cholangitis (PSC) with paediatric-onset inflammatory bowel disease (IBD) affected the disease prognosis, with nearly a 28-fold higher risk for cancer and a ...

Philips has begun rolling out a major update to its cardiovascular ultrasound systems, incorporating a host of imaging quality upgrades and recently cleared artificial intelligence programs. The ...

Zydus Therapeutics has racked up a phase 2b/3 win in primary biliary cholangitis (PBC), clearing the path to a filing to establish the company as a challenger to Gilead Sciences, Intercept ...

Jack Beresford is a Newsweek Senior Internet Culture & Trends Reporter, based in London, UK. His focus is reporting on trending topics on the Internet, he covers viral stories from around the world on ...

Trial met the primary endpoint, with a statistically significant treatment difference in the percentage of patients achieving a clinically meaningful biochemical response with Saroglitazar compared to ...

“I’m emotionally torn from this,” said the Reddit user Abigail Adams is a Human Interest Writer and Reporter for PEOPLE. She has been working in journalism for seven years. Getty A man says he was ...

The EMA has started a review of GSK's treatment candidate for primary biliary cholangitis (PBC), linerixibat, offering hope to patients of an effective treatment for the relentless itching caused by ...

Zydus Therapeutics, a wholly owned subsidiary of Zydus Lifesciences Ltd., a global innovation led healthcare company, announced positive topline results from the pivotal EPICS-III phase 2(b)/3 ...